# PSEE.0 — Context Validation

**Stream:** PSEE.0
**Family:** PSEE
**Date:** 2026-04-05

---

#### EXECUTIVE LAYER

This document confirms that Phase A (BlueEdge source corpus) and Phase B (40.2 structured outputs) refer to the same system, version, and evidence boundary. It establishes the artifact count, folder distribution, and known anomalies of the Phase A corpus before any transformation mapping proceeds. No analysis may begin without this validation passing.

**Value:** Eliminates the risk of mapping a Phase B output back to the wrong source version or a misidentified corpus, which would invalidate all downstream rules.

---

#### METHODOLOGY LAYER

1. Confirm Phase B metadata headers reference the same system and version as Phase A root.
2. Count all MD files in Phase A corpus (source-v3.23/ and docs/) and log their folder distribution.
3. Identify all files at the boundary of the Phase A evidence scope (included, excluded, provenance-only).
4. Flag any structural anomalies (duplicate paths, gray-zone paths, unknown-space positions).

---

#### TECHNICAL LAYER

### A. System Identity Confirmation

| Attribute | Phase A | Phase B | Match |
|-----------|---------|---------|-------|
| System name | BlueEdge Platform | BlueEdge (run_id: run_02_blueedge) | CONFIRMED |
| Version | v3.23.0 (archive filenames) | v3.23.0 (header: version: v3.23.0) | CONFIRMED |
| Canonical repo | blueedge-platform | source-v3.23/extracted/platform/blueedge-platform/ | CONFIRMED |
| Evidence origin root | ~/Projects/blueedge-program-intelligence/ | evidence_origin_root declared in evidence_boundary.md | CONFIRMED |
| Baseline anchor | pios-core-v0.4-final | intake_validation_log: PASS (origin root accessible) | CONFIRMED |

**Verdict:** Phase A and Phase B refer to the same system. Identity match is unambiguous.

---

### B. Phase A Artifact Count

#### B.1 — source-v3.23/ MD files

| File | Path | Role |
|------|------|------|
| 00_extraction_log.md | source-v3.23/analysis/ | Extraction operation record |
| 01_repository_classification.md | source-v3.23/analysis/ | Archive classification and canonical target |
| 02_top_level_component_inventory.md | source-v3.23/analysis/ | Top-level component structure |
| 03_overlap_validation.md | source-v3.23/analysis/ | Standalone vs integrated diff |
| README.md | source-v3.23/extracted/platform/blueedge-platform/ | Platform overview documentation |

**source-v3.23/ MD count: 5**

#### B.2 — docs/ MD files

| Subdirectory | Count | Disposition in 40.2 intake |
|---|---|---|
| docs/reverse_engineering/ | 56 | EXCLUDED — prior analytical output |
| docs/signal-layer/ | 10 | EXCLUDED — prior analytical output |
| docs/streams/ | 8 | Gray-zone — not listed in evidence_boundary.md (neither included nor excluded) |
| docs/execution-telemetry/ | 7 | EXCLUDED — prior analytical output |
| docs/case-study/ | 5 | EXCLUDED — prior analytical output |
| docs/program-charter/ | 5 | EXCLUDED — prior analytical output |
| docs/discipline/ | 3 | Gray-zone — not listed in evidence_boundary.md |
| docs/docs_index_blueedge_program_intelligence.md | 1 | Gray-zone — not listed in evidence_boundary.md |

**docs/ MD count: 95**

**Total Phase A MD corpus: 100 files**

#### B.3 — Phase A non-MD source evidence (used by 40.2)

| Source type | Count | Status |
|---|---|---|
| HTML documentation files | 3 | ACCEPTED — primary evidence |
| Extracted source files (code, config, structural) | ~1,466 | ACCEPTED — primary evidence |
| Raw archives | 3 | PROVENANCE ONLY — not ingested |

**Total ingested evidence: 1,469 files** (per evidence_surface_inventory.md)

---

### C. Folder Distribution

```
blueedge-program-intelligence/
├── source-v3.23/                    ← Phase A primary evidence root (used by 40.2)
│   ├── [root level]                 — 3 HTML documentation files
│   ├── analysis/                    — 4 extraction metadata MDs (support-only)
│   ├── extracted/
│   │   ├── backend/backend/         — 397 source files (PACKAGING_BOUNDARY duplicate noted)
│   │   ├── frontend/frontend/       — 324 source files (PACKAGING_BOUNDARY duplicate noted)
│   │   └── platform/blueedge-platform/  — 741 source files (canonical integrated repo)
│   └── raw/                         — 3 archives (PROVENANCE ONLY)
└── docs/                            ← Phase A manual MD corpus root (excluded from 40.2)
    ├── reverse_engineering/         — 56 MDs — EXCLUDED
    ├── signal-layer/                — 10 MDs — EXCLUDED
    ├── streams/                     — 8 MDs — GRAY-ZONE
    ├── execution-telemetry/         — 7 MDs — EXCLUDED
    ├── case-study/                  — 5 MDs — EXCLUDED
    ├── program-charter/             — 5 MDs — EXCLUDED
    └── discipline/                  — 3 MDs — GRAY-ZONE
```

---

### D. Anomalies

| Anomaly ID | Description | Classification | Action Required |
|---|---|---|---|
| ANOM-01 | extracted/backend/backend/ — double-nested path | PACKAGING_BOUNDARY — outer dir is extraction container, inner is repo root | See source_normalization_log.md for collapse |
| ANOM-02 | extracted/frontend/frontend/ — same pattern | PACKAGING_BOUNDARY | See source_normalization_log.md |
| ANOM-03 | docs/ files excluded from 40.2 intake despite being "manual MD corpus" | Scope distinction: 40.2 accepted raw source evidence only; docs/ = prior analytical outputs | PSEE.0 treats docs/ as Phase A corpus; 40.2 treated source-v3.23/ only |
| ANOM-04 | docs/streams/, docs/discipline/, docs/docs_index: not in evidence_boundary.md inclusion or exclusion | Gray-zone — no explicit disposition | Phase A inventory includes them; 40.2 intake left them unaddressed |
| ANOM-05 | Overlap between standalone (CEU-08, CEU-09) and platform-embedded (CEU-10-BACKEND, CEU-10-FRONTEND) | File-level diff in analysis/03_overlap_validation.md returned zero differences — identical | Canonical target = blueedge-platform; standalones = validation artifacts |

---

#### EVIDENCE LAYER

| Finding | Phase A Source | Phase B Reference |
|---|---|---|
| System = BlueEdge v3.23.0 | Archive filenames in source-v3.23/raw/ | 40.2 headers: version: v3.23.0 |
| Canonical repo = blueedge-platform | analysis/01_repository_classification.md | evidence_surface_inventory.md Domain 5 |
| Total ingested = 1,469 files | source-v3.23/ structure | evidence_surface_inventory.md Summary table |
| docs/ excluded | evidence_boundary.md explicitly_excluded_paths | intake_validation_log.md Check 4 |
| backend/backend duplication | analysis/00_extraction_log.md (extraction structure) | normalized_evidence_map.md OVL-01 |

---

#### LIMITATIONS & BOUNDARIES

- This validation covers MD files and the declared evidence boundary. It does not perform file-level diffs between standalone and platform archives (that is US-01/US-02/US-03 in normalized_evidence_map.md).
- The gray-zone docs/ paths (streams/, discipline/, docs_index) are included in the Phase A inventory but their relationship to 40.2 outputs is not direct — they represent program management artifacts, not raw evidence.
- Phase A "manual MD corpus" in this context = all docs/ MDs + source-v3.23/ analysis/ MDs. The 40.2 intake used source-v3.23/ exclusively.

---

#### REUSABILITY STATEMENT

To apply this context validation to another repository:
1. Confirm Phase B artifact headers contain a `version` or `run_id` field matching the Phase A source version.
2. Count Phase A MDs separately from Phase A source code — they serve different roles in the transformation.
3. Check for path duplication artifacts by looking for repeated directory names within the same path segment.
4. Identify any gray-zone paths in the evidence_boundary (neither included nor excluded) and flag them explicitly.

---

#### STATUS

| Check | Result |
|---|---|
| Phase A ↔ Phase B system identity | CONFIRMED |
| Phase A MD count | 100 files |
| Phase A source file count | 1,469 (ingested) + 3 (provenance) |
| Folder distribution logged | COMPLETE |
| Anomalies flagged | 5 (ANOM-01 through ANOM-05) |
| Path duplication detected | CONFIRMED — see source_normalization_log.md |

**CONTEXT VALIDATION: PASS**
